AXIM BIOTECHNOLOGIES, INC. Deferred Tax Assets, Operating Loss Carryforwards
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Deferred Tax Assets, Operating Loss Carryforwards of $9.72 million as of 2021-12-31, per its 10-K/A filed 2022-04-19.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2022-04-19
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.72M.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.04M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.02M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.18M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2021-12-31 | $9.72M 10-K/A · filed 2022-04-19 |
| 2020-12-31 | $6.04M 10-K/A · filed 2022-04-19 |
| 2019-12-31 | $6.02M 10-K/A · filed 2020-05-20 |
| 2018-12-31 | $3.18M 10-K/A · filed 2020-05-20 |
| 2017-12-31 | $2.49M 10-K · filed 2019-04-08 |
| 2016-12-31 | $2.40M 10-K · filed 2018-03-15 |